ReviewJournal of clinical medicine2024

Safety and Efficacy of Sodium-Glucose Transport Protein 2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Diabetic Kidney Transplant Recipients: Synthesis of Evidence.

Ioannis Bellos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.